이상반응 보고

VAERS ID 2298521
성별 남성
나이 65세
주 코드 CO
제약회사 MODERNA
로트 번호 031A21A
예방접종 횟수
접종일 2021-03-20
발병일 2021-03-20
상태
증상
  • 품질이 좋지 않은 제품이 관리됨(Poor quality product administered)
  • 제품 온도 편차 문제(Product temperature excursion issue)

이환 중 질병

지병

기타 의료

이전 예방접종

알레르기

임상 검사

증상 상세

Doses administered after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion ) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no.
031A21A) for COVID-19 vaccination.
No Medical History information was reported.
On 20-Mar-2021 at 11:54 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .
5 milliliter.
On 20-Mar-2021 at 11:54 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion).
On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion ).
At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (dose administered to patient after more than 1 temperature excursion/vial stored at cooler storage during high-pace COVID-19 vaccination clinic at the time of the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion ) outcome was unknown.
For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age of patient was reported as 65.
52 for dose administered on 20-Mar-2021.
No concomitant medications were reported.
Batch number 031A21A underwent temperature excursion on 20-Mar-2021 with temperature 34 and 37 degrees Fahrenheit from 09:00 AM to 10:00 AM respectively.
This vial was moved to fridge on 09-Mar-2021 and beyond use date for the vial was reported as 08-Apr-2021.
Product moved to clinic on 20-Mar-2021.
Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021.
Vials were only punctured right before administration.
Vaccines were not frozen at time of administration.
It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit.
Temperature recordings were taken using a traceable temperature monitor at every hour.
No treatment medications were reported.
This case was linked to MOD-2022-566976 (Patient Link).